Pharmacy Impact on Outcomes and Costs in the Surgical Suite: Focus on Optimal Hemostatic Practices

This on-demand webcast was originally presented live on November 12 in Atlanta, Georgia as part of the Pharmacy Learning Network Conference Series.

  
Sponsored by North American Center for Continuing Medical Education, LLC

Presenters

Robert MacLaren, PharmD, FCCM, FCCP
Associate Professor
University of Colorado
Skaggs School of Pharmacy and Pharmaceutical Sciences
Critical Care Pharmacy Specialist
University of Colorado Hospital
Denver, Colorado

Mark A. Malesker, PharmD
Professor of Pharmacy Practice
Professor of Medicine
Creighton University School of Medicine
Omaha, Nebraska

Faculty

Bradley A. Boucher, PharmD, FCCP, FCCM
Professor of Clinical Pharmacy
Associate Professor of Neurosurgery
University of Tennessee Health Science Center
Memphis, Tennessee

Intended Learners

This activity is designed for health-system pharmacists.

Learning Objectives

After completing this activity, participants should be able to:

• Evaluate the clinical and economic impact of surgical bleeding and transfusions
• Compare and contrast the clinical profiles of available hemostatic agents
• Promote adherence to Joint Commission standards for achieving hemostasis
• Expand pharmacy involvement in the institutional use of hemostatic agents to ensure best practices and improved outcomes

Activity Overview

This on-demand webcast is available with synchronized slides and audio.

To be eligible for documentation of credit, participants must participate in the full activity, complete the 10-question online post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.

There is no fee associated with this activity.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.

Release Date: December 22, 2011
Expiration Date: December 22, 2012
Estimated time to complete: 1 hour

For questions regarding this educational activity, please call 609-371-1137.

Hardware/Software Requirements

All educational activities are accessible via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. Windows Media Player or compatible alternative, sound card, and speakers are required for streamed audio. The latest version of the Adobe Flash Player is suggested (please download here) for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

Accreditation

In support of improving patient care, NACCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

CPE

This activity is approved for 1 contact hour (0.1 CEU) of continuing pharmacy education (UAN 276-000-11-005-H01-P).

Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by NACCME may contact Assistant Director, Accreditation Services, NACCME, in writing at 300 Rike Drive, Suite A, Millstone Township, NJ 08535. The Assistant Director, Accreditation Services will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Senior Director, Accreditation Services, NACCME, may be made for a second level of review.

This educational activity is a knowledge-based activity.

Independent Clinical Reviewer: Wendy Cantrell, PharmD, BCPS, BCNSP, CACP, Cardiology/Anticoagulation Specialist, University Medical Center of Southern Nevada, Assistant Professor, University of Southern Nevada College of Pharmacy, Las Vegas, Nevada

Planning Committee
The planning committee comprises Bradley A. Boucher, PharmD, FCCP, FCCM; Wendy Cantrell, PharmD, BCPS, BCNSP, CACP; Robert MacLaren, PharmD, FCCM, FCCP; Mark A. Malesker, PharmD; and Kristin Ciszeski, Mary Johnson, Michael Kearney, Nick Lombardi, Randy Robbin, and John Savage, NACCME.

Financial Disclosure and Conflicts of Interest
According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:
Dr. Boucher: Promotional speakers bureau—Eisai, Inc, ZymoGenetics, Inc
Dr. MacLaren: Grant/research support—Hospira; Scientific Advisor—GlaxoSmithKline
Dr. Malesker: Grant/research support—Bayer Pharmaceuticals, Bristol-Myers Squibb, Pfizer, Inc., Pneuma Pharmaceuticals, Wyeth Pharmaceuticals; Consultant—sanofi-aventis U.S., ZymoGenetics, Inc; Promotional speakers bureau—sanofi-aventis U.S., ZymoGenetics, Inc
Dr. Cantrell disclosed no relevant financial relationships with any commercial interests.

Ms. Ciszeski, Ms. Johnson, Mr. Kearney, Mr. Robbin, and Mr. Savage have disclosed no relevant financial relationships with any commercial interests.

Mr. Lombardi: Stock shareholder—Inspire Pharmaceuticals, Inc., ViroPharma, Inc., Vertex Pharmaceuticals

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty has disclosed the following off-label/unapproved use(s) of drugs and/or devices will be discussed: recombinant factor VIIa in cases of refractory bleeding

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2011 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.

Grant Support

Supported by an educational grant from ZymoGenetics, Inc.